home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

289 rows where filing_period = "second_quarter", filing_year = 2011 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 289 ✖

filing_year 1

  • 2011 · 289 ✖

filing_period 1

  • second_quarter · 289 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1106525 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) e6654942-c001-42f6-8eb2-03b62d0106d6 Q2 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2011 second_quarter MED all issues relating to pharmaceutical labeling   25000   0 0 2011-06-14T10:19:32.457000-04:00
1106703 LAW OFFICES OF MARC SHAPIRO 23f806f6-1779-4fd2-a454-baef7910a4c3 Q2 LAW OFFICES OF MARC SHAPIRO 400761290 POZEN INC. 2011 second_quarter MED Amendment of new drug approval provisions of Federal Food, Drug and Cosmetic Act; no bill pending HOUSE OF REPRESENTATIVES 20000   0 0 2011-06-27T14:39:20.957000-04:00
1107021 FEDERAL SOLUTIONS, LLC b7d3f4ea-1369-42f0-98e9-0408ad9dbe2f Q2 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2011 second_quarter MED Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research, education, and development HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-01T10:51:18.630000-04:00
1107030 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 62087f79-7a9a-488b-8cad-a8b670102673 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2011 second_quarter MED Appropriations and Authorization legislation for FY 2012 in health care Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2011-07-01T10:57:21.800000-04:00
1107075 FEDERAL SOLUTIONS, LLC 39b5d021-297b-459f-9fd9-aa9187d441ba Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2011 second_quarter MED Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2011-07-01T11:34:36.597000-04:00
1107176 FRANCIS EDWARD & CRONIN, INC. abc9bd78-50aa-481c-898d-17f17a628bd9 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2011 second_quarter MED Legislation and issues related to Alzheimer's Disease Research Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,Treasury, Dept of,White House Office 10000   0 0 2011-07-02T16:39:53.077000-04:00
1107281 THE KEELEN GROUP, LLC c7161c62-22e5-4490-8dc3-ecdcf276af18 Q2 THE KEELEN GROUP, LLC 323114 AMERICAN PHYSICAL THERAPY ASSOCIATION (APTA) 2011 second_quarter MED Monitored and lobbied upon entire bills of the following: H.R.531, the Access to Frontline Health Care Act of 2011 H.R.1546 / S.829: Medicare Access to Rehabilitation Services Act of 2011; repeal of the Therapy Cap on Outpatient Rehabilitation Services The Medicare Patient Access to Physical Therapists Act (no bill number, formerly H.R.1829 / S.950); to improve access to physical therapists for Medicare beneficiaries HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-05T10:29:19.773000-04:00
1107305 MARSHALL BRACHMAN 4e9576eb-c1fe-4516-8692-af7b5b5be948 Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2011 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2011-07-05T11:22:34.300000-04:00
1107320 MARSHALL BRACHMAN 10914c63-7f1d-4190-b2f6-bf928b011b41 Q2 MARSHALL BRACHMAN 6848 CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE 2011 second_quarter MED reverse cardiac catheterization practice expense cuts HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2011-07-05T11:45:45.253000-04:00
1107359 MARSHALL BRACHMAN 60ec3e69-da5f-45bb-ae90-1192ae8d34a2 2T MARSHALL BRACHMAN 6848 ST VINCENT MEDICAL GROUP FORMERLY KNOWS AS THE CARE GROUP LLC 2011 second_quarter MED oppose cuts to diagnostic imaging in any legislative vehicles;reverse outpatient cardiac catheterization practice expense cuts; support accreditation model for diagnostic imaging HOUSE OF REPRESENTATIVES,SENATE 9000   0 1 2011-07-05T12:19:04.783000-04:00
1107529 GOLDBUG STRATEGIES LLC 762bad91-1dea-4b8a-b88f-4ece55bf0215 Q2 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2011 second_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2011-07-05T17:06:26.163000-04:00
1107541 GOLDBUG STRATEGIES LLC 1ec68fca-e33b-45b1-bae0-9acdc2f2795b Q2 GOLDBUG STRATEGIES LLC 400701094 GENOMIC HEALTH INC. 2011 second_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2011-07-05T17:12:29.537000-04:00
1107621 THE CJR GROUP, INC. 081836a4-36cf-41a4-9682-ab711b281e1e Q2 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2011 second_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-06T10:02:20.763000-04:00
1107625 THE CJR GROUP, INC. d56db4bd-f96e-4c65-831d-c0e1f1104b26 Q2 THE CJR GROUP, INC. 288293 STERIS CORPORATION 2011 second_quarter MED Biomedical issues HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-06T10:11:22.560000-04:00
1107827 MICHAEL SAULS 5fc8a9ca-2b37-41e8-9f53-070ad92e762d 2T MICHAEL SAULS 43638 MIT HOLDING INC 2011 second_quarter MED Educating Congress and regulatory agencies about client's products, seeking EPA registration. Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE     0 1 2011-07-06T16:10:22.040000-04:00
1108223 PARRY, ROMANI, DECONCINI & SYMMS 8ad1f7d5-926f-4440-a25c-ba352dd9add0 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2011 second_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011 - Support funding for medical treatment for HIV positive patients. Support appropriate funding for the ADAP program. Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-07T16:43:07.523000-04:00
1108317 FABIANI & COMPANY a3ce2a77-4dfa-4950-8918-4d3451879865 2T FABIANI & COMPANY 72576 SOVA PHARMACEUTICALS, INC. 2011 second_quarter MED Federal agency interest in and development of pharmaceuticals to treat central sleep apnea. Army, Dept of (Other),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD)     0 1 2011-07-07T18:48:57.287000-04:00
1108631 COZEN O'CONNOR PUBLIC STRATEGIES 63fffd51-81bc-4792-a9f7-f0bfae4e732e Q2 COZEN O'CONNOR PUBLIC STRATEGIES 400459252 THOMAS JEFFERSON UNIVERSITY 2011 second_quarter MED Issues related to grants for medical research development. HOUSE OF REPRESENTATIVES 30000   0 0 2011-07-08T14:15:35.663000-04:00
1108700 WAKE FOREST UNIVERSITY HEALTH SCIENCES afc22932-5f64-47bb-a2a1-171eab2537de Q2 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2011 second_quarter MED NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) America Invents Act HR1249 Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA)   160000 0 0 2011-07-08T14:42:06.707000-04:00
1108724 PARRY, ROMANI, DECONCINI & SYMMS 423624a8-f9f1-4bfe-90f4-2b03140f9aae Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2011 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-07-08T14:58:18.923000-04:00
1108727 PARRY, ROMANI, DECONCINI & SYMMS ac918148-70ff-4dce-b41f-a654227b3c41 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2011 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2011-07-08T15:08:20.700000-04:00
1108746 PARRY, ROMANI, DECONCINI & SYMMS 325761ad-b210-4806-867e-96a937079b48 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2011 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-07-08T15:35:33.777000-04:00
1108787 PARRY, ROMANI, DECONCINI & SYMMS ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2011 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-07-08T16:03:55.353000-04:00
1108799 PARRY, ROMANI, DECONCINI & SYMMS 1b4a13f8-f463-4395-b024-66054c7fc74a Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2011 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-07-08T16:16:02.027000-04:00
1108851 UNIVERSITY OF IOWA e64a6183-f2c1-4dc3-82c4-70f8c3e531c5 Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2011 second_quarter MED FY 2011 Appropriations Residency Caps FY 2012 Appropriations Minority Improvement Medical Affordability Act False Claims Correction Act Research Misconduct Clinical Trials NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act Prevention Research Centers Resident Physician Shortage Health Care Reform Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2011-07-08T16:38:20.290000-04:00
1108915 BEN BARNES GROUP LP 37838855-a51e-4e34-a621-32ddaefe6276 Q2 BEN BARNES GROUP LP 5415 HUNTSMAN CANCER INSTITUTE 2011 second_quarter MED Medical research HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2011-07-10T11:20:23.193000-04:00
1108924 BEN BARNES GROUP LP 76a700ba-beb3-4423-87d1-2f8d3282ee88 Q2 BEN BARNES GROUP LP 5415 OKLAHOMA RESEARCH MEDICAL FOUNDATION 2011 second_quarter MED Medical research SENATE 20100   0 0 2011-07-10T12:02:28.300000-04:00
1108983 PAW AND ASSOCIATES a99ec091-ab61-4626-8872-a50e3e4805af Q2 PAW AND ASSOCIATES 74875 SCOTTSDALE HEALTHCARE 2011 second_quarter MED Educate officials on the capabilities to respond to local, regional and natural disasters using a military partnership as a cornerstone Air Force, Dept of,Army, Dept of (Other),Defense, Dept of (DOD),Natl Guard 10000   0 0 2011-07-10T14:30:07.687000-04:00
1109070 HOLLAND & KNIGHT LLP f2ce45fe-2461-4591-9db2-f86c7edcd1e5 Q2 HOLLAND & KNIGHT LLP 18466 SHIRE PHARMACEUTICALS, INC 2011 second_quarter MED Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products. Participate in FDA stakeholder meetings re Prescription Drug User Fee program. Met with FDA officials regarding programs to support development of products for rare diseases. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-07-11T11:18:04.190000-04:00
1109131 HOLLAND & KNIGHT LLP e3716adb-e53e-4d18-b5fd-b2ce6ad324fe Q2 HOLLAND & KNIGHT LLP 18466 ALLIANCE FOR REGENERATIVE MEDICINE 2011 second_quarter MED Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA. Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE 80000   0 0 2011-07-11T11:49:36.593000-04:00
1109169 HOLLAND & KNIGHT LLP 317a6159-365e-446d-82e7-6d42ed02022e 2T HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2011 second_quarter MED Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 1 2011-07-11T12:02:58.890000-04:00
1109193 HOLLAND & KNIGHT LLP 6a9d74ff-c691-4d13-9e68-af110e2ca8cb 2T HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2011 second_quarter MED Biomedical Research; CDC Hemophilia program; HRSA Hemophilia Program Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 40000   0 1 2011-07-11T12:08:08.093000-04:00
1109206 HOLLAND & KNIGHT LLP 1ed1c57b-d601-4451-8f83-4ffaa9f08658 2T HOLLAND & KNIGHT LLP 18466 AABB 2011 second_quarter MED Issues related to blood transfusion; tissue transplantation and other laboratory services; blood safety issues; biovigilance programs at CDC and HHS. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2011-07-11T12:14:15.407000-04:00
1109368 HAAKE & ASSOCIATES d69e0327-99ec-400e-956f-bc302a4092dd Q2 HAAKE & ASSOCIATES 17226 CRUCELL SWITZERLAND AG 2011 second_quarter MED Work on authorization/ approval, appropriations, and policy matters regarding vaccines. Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) 20000   0 0 2011-07-11T13:52:42.590000-04:00
1109465 AMERICAN COLLEGE OF CLINICAL PHARMACY c604db59-9568-432b-91bb-b3e54d544075 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2011 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   59600 0 0 2011-07-11T14:57:37.943000-04:00
1109468 HAAKE & ASSOCIATES 1e6854b1-d7e4-4d87-97b5-2a98d804a611 Q2 HAAKE & ASSOCIATES 17226 MEDINSTILL, INC. 2011 second_quarter MED Medical device approval and policy matters. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-11T15:03:40.443000-04:00
1109506 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY e381a45d-2c31-407a-96a5-2110e46f1398 Q2 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 3435 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2011 second_quarter MED Appropriations for Federal Health Agencies Elimination of Physician Signature Requirement Under Medicare PFS Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortag Regulation of Laboratory Developed Tests; Debt Ceiling Negotiations Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),SENATE   61000 0 0 2011-07-11T15:56:07.547000-04:00
1109780 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7fc1ddb0-6cbf-4eb4-a946-98377eca84c9 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2011 second_quarter MED No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, Tuberous Sclerosis HR 1473, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2011-07-12T10:11:43.047000-04:00
1109789 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 89ca5832-74a2-441e-b150-cfecf3e7d258 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 SAGE PUBLICATIONS, INC. 2011 second_quarter MED No Bill#, Federal Research Public Access Act National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, NIH Open Access Policy, Department of Education Title II Funding No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-12T10:14:45.810000-04:00
1109809 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 338d276b-c981-4d01-96b5-ae17b5e7b9e7 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION 2011 second_quarter MED No Bill #, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research Continuing Resolutions, FY 2011 HR 2123/S 1167, Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-12T10:25:53.357000-04:00
1109827 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f671a304-551e-4254-b390-d3f9582b8567 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION 2011 second_quarter MED No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Continuing Resolutions, FY 2011 Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2011-07-12T10:34:00.373000-04:00
1109862 SQUIRE PATTON BOGGS 44620133-9cf6-4e9e-abe3-04edad41932b Q2 SQUIRE PATTON BOGGS 30906 GENENTECH, INC. 2011 second_quarter MED Implementation of healthcare reform law. FDA Drug Approval and appeal oversight process. Support for legislation preserving patient and physician choice in medical treatments. PATIENTS Act (S.660) HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2011-07-12T10:40:13.437000-04:00
1109897 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e82b578f-4fc9-487a-86b5-3338a8857d90 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 COOLEY'S ANEMIA FOUNDATION 2011 second_quarter MED Drug review and approval process Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-12T10:52:33.950000-04:00
1109961 HEALTHFUTURES, LLC fca49cc1-cebf-4678-86eb-13e2933ccb03 2T HEALTHFUTURES, LLC 400359646 TETHYS BIOSCIENCE 2011 second_quarter MED Regulation of laboratory developed tests. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2011-07-12T11:23:09.527000-04:00
1109984 HEALTHFUTURES, LLC 1468d393-c529-4d82-a273-a5da1a227a3f 2T HEALTHFUTURES, LLC 400359646 NAVIGENICS, INC. 2011 second_quarter MED Oversight and regulation of genetic testing Direct to consumer genetic testing Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2011-07-12T11:26:18.057000-04:00
1110134 HEALTHFUTURES, LLC 0ff748d3-cd58-4b0f-92f7-bc605334d361 2T HEALTHFUTURES, LLC 400359646 ASSOCIATION FOR MOLECULAR PATHOLOGY 2011 second_quarter MED Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#, Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act; No Bill#, BETTER Patient Care Act; HR 1249, American Invents Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE 30000   0 1 2011-07-12T13:46:55.473000-04:00
1110148 HEALTHFUTURES, LLC 69aa4e86-2534-4e83-b839-bc6da99ec508 2T HEALTHFUTURES, LLC 400359646 LIFE TECHNOLOGIES 2011 second_quarter MED No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory-developed tests No Bill#, BETTER Patient Care Act Whole genome sequencing Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 1 2011-07-12T14:03:08.113000-04:00
1110169 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4a94d196-6327-4f15-8310-3b7cb185db8f Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ONYX PHARMACEUTICALS 2011 second_quarter MED Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-12T14:13:21.830000-04:00
1110318 DALRYMPLE & ASSOCIATES, LLC 07313929-b4d6-489e-b26c-01c69947964f Q2 DALRYMPLE & ASSOCIATES, LLC 5073 EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) 2011 second_quarter MED Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 46000   0 0 2011-07-12T15:25:56.157000-04:00
1110348 DALRYMPLE & ASSOCIATES, LLC 91537c50-e396-4e75-81cc-7562e3121d24 Q2 DALRYMPLE & ASSOCIATES, LLC 5073 SANOFI PASTEUR 2011 second_quarter MED Vaccine research and development legislation, funding, appropriations and oversight. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office 46000   0 0 2011-07-12T15:35:13.267000-04:00
1110618 RAY C CULVER III 4341372b-5cc4-443a-b25c-f61eb00c5a5c Q2 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2011 second_quarter MED Funding for ARS Human Nutrition Centers in HR 2112, FY12 Agricultural Appropriations HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-12T21:19:45.993000-04:00
1110949 SRI INTERNATIONAL c1ebdf42-754a-4953-9dab-9f53c27bb8fb Q2 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2011 second_quarter MED FY12 House Defense Appropriations (HR 2219) FY12 House and Senate Defense Authorizations (HR 1540/S 1253) HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2011-07-13T10:55:57.027000-04:00
1111242 ASSN OF MEDICAL DEVICE REPROCESSORS aa926d53-c387-4687-8534-4255d0659e89 Q2 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2011 second_quarter MED Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry. HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2011-07-13T13:25:54.373000-04:00
1111379 DALRYMPLE & ASSOCIATES, LLC b0d8de59-60e5-47eb-9dde-66bd0e0cdc8a Q2 DALRYMPLE & ASSOCIATES, LLC 5073 DISCOVERY LABORATORIES 2011 second_quarter MED Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 5000   0 0 2011-07-13T14:36:04.327000-04:00
1111436 DALRYMPLE & ASSOCIATES, LLC 8de26d35-41f1-47ae-b21d-62a240e58a54 Q2 DALRYMPLE & ASSOCIATES, LLC 5073 BRIGHTON BIOTECH, INC. 2011 second_quarter MED Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 15000   0 0 2011-07-13T14:49:33.590000-04:00
1111468 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 1c964f4a-03df-42d8-9deb-b7b59790587e Q2 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2011 second_quarter MED No bill #: Advocate for disability and rehabilitation prioirities of the Patient Centered Outcomes Research Institute, espcially regarding comparative effectiveness research. Advocate for elevation of the National Center for Medical Rehabilitation Research within the National Institutes of Health. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   120000 0 0 2011-07-13T14:54:44.530000-04:00
1111495 BEN BARNES GROUP LP 102ab634-41e8-437d-b46b-2a5225765502 Q2 BEN BARNES GROUP LP 5415 FAIR LABORATORY PRACTICES ASSOCIATION 2011 second_quarter MED Bring attention to prevention of unfair billing practices by laboratories for Medicare services HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-13T15:04:59.873000-04:00
1112097 CORNERSTONE GOVERNMENT AFFAIRS, INC. 37d99904-bebe-4d58-874f-6af042d91f2f Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 PATH 2011 second_quarter MED Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-14T10:48:21.030000-04:00
1113156 BOB MOSS ASSOCIATES 30292a6d-e7f1-4375-b711-abff79557875 2T BOB MOSS ASSOCIATES 51877 BURNHAM INSTITUTE FOR MEDICAL RESEARCH (NOW STANFORD-BURNHAM MEDICAL RESEARCH) 2011 second_quarter MED Sewcuring continued support from Congress for Sanford Burnham's medical research p[rograms. HOUSE OF REPRESENTATIVES,SENATE 15000   0 1 2011-07-14T17:38:35.967000-04:00
1113285 CHILDREN'S HOSPITAL BOSTON 4d1564bb-5b76-4f3a-9175-9c09220b07b3 Q2 CHILDREN'S HOSPITAL BOSTON 9066 CHILDREN'S HOSPITAL BOSTON 2011 second_quarter MED Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   50000 0 0 2011-07-15T08:06:53.987000-04:00
1113323 MEHLMAN CONSULTING, INC. df2deb25-985a-4b98-a69f-358adb73dbb0 Q2 MEHLMAN CONSULTING, INC. 284950 NATIONAL VENTURE CAPITAL ASSOCIATION 2011 second_quarter MED FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 60000   0 0 2011-07-15T08:54:13.440000-04:00
1113404 WEBMD HEALTH CORP. 51dd346e-361b-4b2b-a64d-716ab0310b7c Q2 WEBMD HEALTH CORP. 55473 WEBMD HEALTH CORP 2011 second_quarter MED Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and the deduction of expenses associated with advertising; Personal health records. SENATE   40000 0 0 2011-07-15T09:27:43.157000-04:00
1113653 LIFE TECHNOLOGIES CORPORATION f2085cd1-fd5f-4144-aaf3-f27a0689e629 Q2 LIFE TECHNOLOGIES CORPORATION 400391833 LIFE TECHNOLOGIES CORPORATION 2011 second_quarter MED BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests. HOUSE OF REPRESENTATIVES,SENATE   210000 0 0 2011-07-15T11:18:02.533000-04:00
1113957 THE CORMAC GROUP, LLC 8d835861-f42c-4def-9edb-b5ccb43bf972 Q2 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2011 second_quarter MED Appropriations HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-15T12:23:48.207000-04:00
1114519 GENENTECH, INC c0acace8-c62f-489c-b8d4-47049f65432c Q2 GENENTECH, INC 15920 GENENTECH INC 2011 second_quarter MED Public Law 111-148, the Patient Protection and Affordable Care Act of 2009 - Implementation issues related to the authorization for comparatice effective research and the Patient-Centered Outcomes Research Institute. HOUSE OF REPRESENTATIVES,SENATE   1140295 0 0 2011-07-15T15:29:33.307000-04:00
1114576 CEPHEID 37a1d51e-33c8-47fc-b7e7-ccfd9191f932 Q2 CEPHEID 400270233 CEPHEID 2011 second_quarter MED See page five Lobbying Issues: molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues HR 436/ S 17, Protect Medical Innovation Act of 2011 HR 488, Save Our Medical Devices Act of 2011 HR 755, Investing in Our Future Act of 2011 HR 965/ S 1211, Preservation of Antibiotics for Medical Treatment Act of 2011 HR 2182 Generating Antibiotic Incentives Now (GAIN) S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE   30000 0 0 2011-07-15T15:47:01.777000-04:00
1114614 PERSONALIZED MEDICINE COALITION da6e457e-a304-4c5c-a6d9-c39e5e657543 Q2 PERSONALIZED MEDICINE COALITION 40046362 PERSONALIZED MEDICINE COALITION 2011 second_quarter MED CER, CMS, Coverage of Genetic Testing Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   68403 0 0 2011-07-15T16:11:19.150000-04:00
1114632 PERSONALIZED MEDICINE COALITION 8f5e5a43-48c5-4d71-a881-34a25de32fe8 2A PERSONALIZED MEDICINE COALITION 40046362 PERSONALIZED MEDICINE COALITION 2011 second_quarter MED CER, CMS, Coverage of Genetic Testing Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   6403 0 0 2011-07-15T16:17:32.027000-04:00
1114955 THE HARRIS FIRM 9f187d41-61b0-4213-aead-0d909e211dba Q2 THE HARRIS FIRM 68376 DIRECT MESSAGE LAB 2011 second_quarter MED Regarding funding for FY 11 pertaining to software communication system for chronic disease management Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-15T18:50:15.697000-04:00
1115008 DANIELLE ORGAN PETERS 4f75d6e9-5d17-40f9-be92-f51c79e62ac8 Q2 DANIELLE ORGAN PETERS 400427062 FABIANI & COMPANY ON BEHALF OF NANOTHERAPEUTICS INC. 2011 second_quarter MED Funding for flexible manufacturing to address public health emergencies Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-16T06:52:58.800000-04:00
1115241 THE PETRIZZO GROUP, INC. 69a297c2-56dd-45e2-bf26-84fc81c5a36f Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2011 second_quarter MED Advocated for legislativion to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-16T20:49:23.977000-04:00
1115244 THE PETRIZZO GROUP, INC. 79061dfc-3ffb-49ae-852e-305b282edf7c Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE BIOMEDICAL RESEARCH INSTITUTE 2011 second_quarter MED Advocate for funding to support next - generation drug development for Leishmaniasis. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-16T20:54:24.977000-04:00
1115250 THE PETRIZZO GROUP, INC. 61d6c95d-7da7-4461-be02-45bb558d3893 Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE CANCER CARE ALLIANCE 2011 second_quarter MED Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-16T21:00:25.913000-04:00
1115252 THE PETRIZZO GROUP, INC. 00966db2-9c1d-48f3-9c57-189c778678d2 Q2 THE PETRIZZO GROUP, INC. 305932 SAGE THERAPEUTICS, INC. 2011 second_quarter MED Advocated for federal funding to support development of neuroactive steroids to yield therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-16T21:11:26.897000-04:00
1115392 W STRATEGIES, LLC 4b7319f5-0af1-447a-95a3-108d17f095a2 Q2 W STRATEGIES, LLC 400605842 23ANDME, INC. 2011 second_quarter MED Issues relating to FDA regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-17T13:28:04.440000-04:00
1115792 VAN SCOYOC ASSOCIATES b6d16617-666d-4571-9237-afc1606ae8f2 Q2 VAN SCOYOC ASSOCIATES 39837 MEDICINES FOR MALARIA VENTURE 2011 second_quarter MED USAID and Malaria research and development issues and initiatives HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID) 30000   0 0 2011-07-18T05:44:00.197000-04:00
1115794 VAN SCOYOC ASSOCIATES 6af8d8be-ee2e-47b4-bdfe-2af9c12f2758 Q2 VAN SCOYOC ASSOCIATES 39837 CUREMARK LLC 2011 second_quarter MED Therapeutic treatment for autism issues generally. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2011-07-18T05:52:01.293000-04:00
1116302 WHITMER & WORRALL, LLC ee7ec830-a9c5-4cb2-8338-cfa74b76298f Q2 WHITMER & WORRALL, LLC 292892 NEURO KINETICS 2011 second_quarter MED Issues related to Traumatic Brain Injury (TBI). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-18T10:06:57.527000-04:00
1116310 POLICY DIRECTIONS INC. b8f1f628-d97f-4ee9-8743-a7d251cedc2b 2T POLICY DIRECTIONS INC. 31747 ADVANCED LIFE SCIENCES 2011 second_quarter MED FDA regulatory pathway for new antibiotic medicines. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 1 2011-07-18T10:06:59.290000-04:00
1116388 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS ada10fb9-6a1f-4253-8d11-a9c07f16c7b0 Q2 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 1375 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 2011 second_quarter MED Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ) Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE   157926 0 0 2011-07-18T10:20:46.260000-04:00
1116941 POLICY DIRECTIONS INC. 880e57a5-4c98-4c08-ba11-b803e4594f36 Q2 POLICY DIRECTIONS INC. 31747 VITAPATH GENETICS, INC. 2011 second_quarter MED New regulatory requirements for diagnostics. Seeking federal funding for novel genetic diagnostic tests. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-18T11:29:51.853000-04:00
1116973 KSCW, INC. 48c1617e-a380-4191-bfe2-919532abbae1 Q2 KSCW, INC. 21596 INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS 2011 second_quarter MED Legislation and regulation affecting the Medical device industry HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-18T11:35:10.320000-04:00
1117201 MEHLMAN CONSULTING, INC. eeaa21ba-f73d-4da3-90bf-4a781c329efc Q2 MEHLMAN CONSULTING, INC. 284950 MAYO CLINIC 2011 second_quarter MED NIH appropriations HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-18T12:30:08.710000-04:00
1117259 POLICY DIRECTIONS INC. 9f2af335-4f90-499a-ba2e-22a5789b4bc7 Q2 POLICY DIRECTIONS INC. 31747 BAYLOR COLLEGE OF MEDICINE 2011 second_quarter MED S. 606 - Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-18T12:47:37.383000-04:00
1117603 TURNER & GOSS LLP 7229c5f4-ef39-4b0c-853c-9d691f205513 Q2 TURNER & GOSS LLP 316310 CYSTIC FIBROSIS FOUNDATION 2011 second_quarter MED Reauthorization of Prescription Drug User Fee Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-18T13:43:27.977000-04:00
1117663 PARALYZED VETERANS OF AMERICA 73b73c8c-3933-4be4-b022-0d0781b69379 Q2 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2011 second_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   86931 0 0 2011-07-18T13:54:55.477000-04:00
1117969 GROUP HEALTH COOPERATIVE 76b00ce5-dc09-418d-8e7a-5df8f969fc65 Q2 GROUP HEALTH COOPERATIVE 17022 GROUP HEALTH COOPERATIVE 2011 second_quarter MED Issues related to health reform legislation and regulation including Medicare Advantage; insurance regulation changes; insurance taxes; health cooperatives; health systems reserach topics such as the patient-centered medical home; the Patient Protection and Affordable Care Act. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office   110000 0 0 2011-07-18T14:33:27.473000-04:00
1118122 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 1b066560-b869-4bee-a46e-f15ed475fd4a Q2 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 48975 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 2011 second_quarter MED Reduce health care disparities in service and in research. Support the Minority AIDS initiative. Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Defense, Dept of (DOD),Education, Dept of,Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Federal Bureau of Investigation (FBI),Federal Communications Commission (FCC),Federal Deposit Insurance Corporation (FDIC),Federal Emergency Management Agency (FEMA),Federal Reserve System,Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Interior, Dept of (DOI),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Park Service (NPS),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Office of Thrift Supervision (OTS),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Commission on Civil Rights,U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA),Voice of America,White House Office   50000 0 0 2011-07-18T14:55:52.317000-04:00
1118272 THE OUTLAW GROUP 2277dbd7-840f-4c57-9790-46f045a3a3f0 Q2 THE OUTLAW GROUP 46095 AMERICAN TINNITUS ASSOCIATION 2011 second_quarter MED Legislation to increase federal support for research aimed at preventing, treating and curing tinnitus. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-18T15:09:01.643000-04:00
1118299 DENNY MILLER ASSOCIATES a14a9d46-47f7-447c-b62c-de8764ccb6e4 Q2 DENNY MILLER ASSOCIATES 25328 SABEY CORPORATION 2011 second_quarter MED Oversight and implementation of the Patient Protection and Affordable Care Act (Public Law 111-148), provisions relating to the Center for Medicare and Medicaid Innovation grant program. Federal grant funding through the National Institutes of Health. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-18T15:13:15.787000-04:00
1118424 DENNY MILLER ASSOCIATES 233a33ba-6abe-4d8c-b18b-f6e8056f82c2 Q2 DENNY MILLER ASSOCIATES 25328 ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER 2011 second_quarter MED Labor, Health and Human Services, Education Appropriations Bill, 2012, provisions relating to rural health care. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-18T15:31:21.317000-04:00
1118581 OGR 7c862f24-c798-4396-8828-ddb69ace00f8 Q2 OGR 48827 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2011 second_quarter MED Issues related to insuring access to over-the-counter drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-18T16:03:53.317000-04:00
1118707 LATHAM & WATKINS LLP ae7a0385-3a0d-485f-8220-5eaff4957988 Q2 LATHAM & WATKINS LLP 22201 BOSTON SCIENTIFIC CORPORATION 2011 second_quarter MED Congressional oversight of the Food and Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-18T16:33:02.427000-04:00
1119136 FIRST STRATEGIC 30f7f61a-c66d-4d19-b491-af4215c897f1 Q2 FIRST STRATEGIC 91091 PHOENIX CHILDREN'S HOSPITAL 2011 second_quarter MED Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-18T18:58:36.063000-04:00
1119213 BROWNSTEIN HYATT FARBER SCHRECK, LLP 4f80b05d-c0b6-4122-9c88-15a4e3bff806 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ABBOTT LABORATORIES 2011 second_quarter MED Healthcare reform Legal reform Theft of medical products   60000   0 0 2011-07-18T19:59:14.093000-04:00
1119218 THE PETRIZZO GROUP, INC. a93ed7ac-2cc1-4092-a065-d0fda86ec53d Q2 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2011 second_quarter MED Advocated for federal funding for the Allen Institute Human Brain Atlas Project, which will create a comprehensive 3-dimensional map detailing gene expression in the human brain. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-18T20:06:15.690000-04:00
1119219 THE PETRIZZO GROUP, INC. e8a2e0bc-c178-40d7-aec5-5d247a49a881 Q2 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2011 second_quarter MED Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011 federal funding. Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-18T20:10:16.533000-04:00
1119225 THE PETRIZZO GROUP, INC. 56bb2b4c-5770-4f00-baae-29f51d17af19 Q2 THE PETRIZZO GROUP, INC. 305932 FATE THERAPEUTICS, INC. 2011 second_quarter MED Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Defense Advanced Research Projects Agency (DARPA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-18T20:12:18.380000-04:00
1119229 FIRST STRATEGIC d98becf6-7356-4292-a34f-046a3a8fe011 Q2 FIRST STRATEGIC 91091 TRANSLATIONAL GENOMICS RESEARCH INSTITUTE 2011 second_quarter MED The Creating Hope Act - issues regarding drug development for pediatric rare diseases. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-18T20:15:19.290000-04:00
1119360 PHOENIX CHILDREN'S HOSPITAL 1334f275-7964-4963-b583-965a5721b693 Q2 PHOENIX CHILDREN'S HOSPITAL 400381743 PHOENIX CHILDREN'S HOSPITAL 2011 second_quarter MED Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2011-07-18T21:57:28.027000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2200.538ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API